Company Filing History:
Years Active: 2025
Title: Bruce Szczepankiewicz: Innovator in Nicotinamide Mononucleotide Derivatives
Introduction
Bruce Szczepankiewicz is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of nicotinamide mononucleotide derivatives. His work focuses on the potential therapeutic applications of these compounds in promoting cellular health.
Latest Patents
Szczepankiewicz holds a patent for "Nicotinamide mononucleotide derivatives and their uses." This invention encompasses compositions of nicotinamide mononucleotide derivatives and their methods of use. It also details methods for preparing these derivatives, which are crucial for developing pharmaceutical compositions and nutritional supplements. The invention aims to enhance intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues, which is vital for treating diseases and improving cell and tissue survival.
Career Highlights
Bruce Szczepankiewicz is associated with Metro International Biotech, LLC, where he applies his expertise in biochemistry to advance innovative solutions in health and wellness. His work has the potential to impact various therapeutic areas, making him a valuable asset in the biotech industry.
Collaborations
Szczepankiewicz collaborates with esteemed colleagues such as James M Mckearin and Karl D Normington. These partnerships enhance the research and development efforts at Metro International Biotech, LLC, fostering innovation in the field.
Conclusion
In summary, Bruce Szczepankiewicz is a pioneering inventor whose work on nicotinamide mononucleotide derivatives holds promise for advancing health solutions. His contributions to the field of biochemistry are noteworthy and reflect his commitment to improving cellular health through innovative research.